From: Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
Time after injection
Cerebellar Ro0711401 levels
(pg/mg tissue)
30 min
211 ± 20
60 min
135 ± 10
90 min
100 ± 9
120 min
100 ± 40
240 min
80 ± 30
24 hours
N.D.